CTRI/2021/01/030796Completed未知
Evaluation of Cellular Immunity in SARS-CoV-2 recovered subjects as an alternative to IgG testing - NI
Atrimed Biotech LLP0 sites60 target enrollmentStarted: TBDLast updated:
Trial Snapshot
- Phase
- 未知
- Status
- Completed
- Sponsor
- Enrollment
- 60
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Observational
Eligibility Criteria
Inclusion Criteria
- •1) Both male and female adult populations aged from 18 to 60 years with background comorbidities such as Type II Diabetes mellitus(DM), hypertension(HTN), Bronchial asthma, Ischemic heart disease(IHD), cerebrovascular accidents(CVA), Thyroid disorders will be included in the study.
- •2) Convalescent, RTPCR negative for SARS-CoV2 ( 2 weeks), IgG positive for SARS CoV2 , asymptomatic patients as determined by the principal investigator/ physician.
- •3) SARS CoV2 frontline workers are included as test subjects.
- •4) Non health care workers are included as control subjects. 5) Volunteer is willing and able to comply with all the trial requirements. 5) All volunteers obtained written informed consent form in English as well as native language, Kannada
Exclusion Criteria
- •1) Patients with active COVID-19 infection( PCR positive, IgM positive).
- •2) Known patients of HIV, Hepatitis-B/C , H1N1.
- •3) Pregnant and lactating women.
- •4) Patients with known autoimmune diseases on immuno-suppressants and steroids.
- •5) Patients who have participated in another clinical trial within the previous 30 days.
- •6) Patient not willing to give informed consent form
Investigators
Similar Trials
Not yet recruiting
Not Applicable
EVALUATION OF CELLULAR IMMUNITY IN SARS-CoV-2 RECOVERED AND/OR VACCINATED SUBJECTS TO SARS-CoV-2 B-1.1.529 (OMICRON) VARIANT BY A SIMPLE CELLULAR IMMUNITY TESTCTRI/2022/02/039925Atrimed Pharmaceuticals Pvt Ltd
Completed
Not Applicable
Immune response to COVID-19 vaccination in patients with autoimmune disorders on various types of immunosuppressive treatmentsImmune response to COVID-19 (SARS-CoV-2 infection) vaccination in patients on immunosuppressive therapyInfections and InfestationsISRCTN68832164Charles University199
Not yet recruiting
Not Applicable
Analysis of the SARS-CoV-2 specific immune response in persons with SARS-CoV-2 infection (COVID-19)07.1 COVID-19DRKS00023086niversitätsklinikum Homburg190
Completed
Not Applicable
Study of Immune Response During SARS-CoV-2 Infection - (COVID-19)New Coronavirus Disease (COVID-19), Infection With SARS-CoV-2NCT04355351Centre Hospitalier Universitaire de Nice303
Recruiting
Not Applicable
Immunological assessment of SARS-CoV-2 in IENIMINI cohort individuals with influenza like symptoms.COVID19infection caused by SARS-CoV-2 virus1000381610047438NL-OMON54879eids Universitair Medisch Centrum560
